These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 14185658)

  • 1. LAEVADOSIN IN TREATMENT OF DUCHENNE TYPE OF MUSCULAR DYSTROPHY: PRELIMINARY RESULTS OF A DOUBLE-BLIND CONTROLLED TRIAL.
    PEARCE JM; GUBBAY SS; HARDY J; PENNINGTON RJ; NEWELL DJ; WALTON JN
    Br Med J; 1964 Oct; 2(5414):915-7. PubMed ID: 14185658
    [No Abstract]   [Full Text] [Related]  

  • 2. LAEVADOSIN FOR MUSCULAR DYSTROPHY.
    THOMSON WH
    Br Med J; 1964 Oct; 2(5417):1135-6. PubMed ID: 14198741
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of muscular dystrophy with "Laevadosin".
    Lip P; Flanagan J; Murray P
    Med J Aust; 1969 Jun; 1(26):1386. PubMed ID: 5797171
    [No Abstract]   [Full Text] [Related]  

  • 4. LAEVADOSIN IN MUSCULAR DYSTROPHY.
    JACOBS J
    Br Med J; 1965 Sep; 2(5463):704. PubMed ID: 14337743
    [No Abstract]   [Full Text] [Related]  

  • 5. SERUM ENZYME STUDIES IN MUSCLE DISEASE. III. SERUM CREATINE KINASE ACTIVITY IN RELATIVES OF PATIENTS WITH THE DUCHENNE TYPE OF MUSCULAR DYSTROPHY.
    PEARCE JM; PENNINGTON RJ; WALTON JN
    J Neurol Neurosurg Psychiatry; 1964 Jun; 27(3):181-5. PubMed ID: 14175282
    [No Abstract]   [Full Text] [Related]  

  • 6. [The treatment of progressive muscular dystrophy with nucleosides and nucleotides. Clinical and serologic findings (aldolase and creatinphosphokinase)].
    Ceccarelli A; Leone P; Moretti A
    Clin Pediatr (Bologna); 1967 Sep; 49(9):468-75. PubMed ID: 5608288
    [No Abstract]   [Full Text] [Related]  

  • 7. A mathematical analysis of creatine kinase activity in the course of Duchenne muscular dystrophy.
    Pernice W; Guggolz MA; Guggolz M; Beckmann R; Wais U
    Muscle Nerve; 1986 May; 9(4):333-40. PubMed ID: 3713738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [MUSCULAR DYSTROPHY OF THE DUCHENNE TYPE: ENZYMATIC ACTIVITY IN A FAMILIAL GROUP OF SUBJECTS WITH AND WITHOUT CLINICAL MANIFESTATIONS].
    MARZUOLI U; RUBINO R; BOCCALATTE G
    Minerva Med; 1965 Jan; 56():90-2. PubMed ID: 14248694
    [No Abstract]   [Full Text] [Related]  

  • 9. LAEVADOSIN IN MUSCULAR DYSTROPHY.
    THOMSON WH
    Br Med J; 1965 Sep; 2(5462):647. PubMed ID: 14331636
    [No Abstract]   [Full Text] [Related]  

  • 10. TREATMENT OF MUSCULAR DYSTROPHY WITH A NUCLEOTIDES- NUCLEOSIDES COMBINATION.
    GUEST KE; MCLAY WD
    Br J Clin Pract; 1964 Jul; 18():395-400. PubMed ID: 14196785
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serum aldolase and creatine phosphokinase in progressive muscular dystrophy].
    Ceccarelli A; Leone P
    Clin Pediatr (Bologna); 1967 May; 49(5):237-45. PubMed ID: 6080497
    [No Abstract]   [Full Text] [Related]  

  • 12. The progression of Duchenne muscular dystrophy: clinical trial of allopurinol therapy.
    Stern LM; Fewings JD; Bretag AH; Ballard FJ; Tomas FM; Cooper DM; Goldblatt E
    Neurology; 1981 Apr; 31(4):422-6. PubMed ID: 7012668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [THE BEHAVIOR OF SERUM ALDOLASE AND TRANSAMINASE ACTIVITY IN PROGRESSIVE MUSCULAR DYSTROPHY IN BASIC CONDITIONS AND AFTER ANABOLIC AND RE-METABOLIZING THERAPY].
    BUSCAINO GA; SEPE O
    Acta Neurol (Napoli); 1964; 19():523-46. PubMed ID: 14208396
    [No Abstract]   [Full Text] [Related]  

  • 14. [Differential diagnosis of Becker and Duchenne muscular dystrophy].
    Alvarez Leal M; Hernández Sifuentes PM; Pérez-Zuno JA
    Gac Med Mex; 1994; 130(6):454-8. PubMed ID: 7557060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SERUM ENZYME STUDIES IN MUSCLE DISEASE. II. SERUM CREATINE KINASE ACTIVITY IN MUSCULAR DYSTROPHY AND IN OTHER MYOPATHIC AND NEUROPATHIC DISORDERS.
    PEARCE JM; PENNINGTON RJ; WALTON JN
    J Neurol Neurosurg Psychiatry; 1964 Apr; 27(2):96-9. PubMed ID: 14167093
    [No Abstract]   [Full Text] [Related]  

  • 16. [Critical evaluation of changes of serum CK after exertion in the identification of carriers of Duchenne's muscular dystrophy].
    Cordone G; Venzano V; Rossi G; Cavallero G; Minetti C
    Pediatr Med Chir; 1984; 6(6):819-22. PubMed ID: 6545595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TREATMENT OF MUSCULAR DYSTROPHY.
    WALTON JN
    Dev Med Child Neurol; 1964 Apr; 6():194-5. PubMed ID: 14141744
    [No Abstract]   [Full Text] [Related]  

  • 18. [The treatment of muscular dystrophy with the nucleoside-nucleotide mixture Laevadosine].
    Radu H; Stenzel K; Migea S; Bordeianu L
    Munch Med Wochenschr; 1967 Dec; 109(51):2702-5. PubMed ID: 4873261
    [No Abstract]   [Full Text] [Related]  

  • 19. CYSTEINE-STIMULATED SERUM CREATINE KINASE IN HEALTH AND DISEASE.
    OKINAKA S; SUGITA H; MOMOI H; TOYOKURA Y; WATANABE T; EBASHI F; EBASHI S
    J Lab Clin Med; 1964 Aug; 64():299-305. PubMed ID: 14202791
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of preclinical Duchenne muscular dystrophy and its female carriers.
    Beckmann R
    Isr J Med Sci; 1977 Feb; 13(2):102-6. PubMed ID: 863671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.